Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Ljungman

Showing results (81-90 of 320) with videos related to

Pageof 32
Sort By:
Scandinavian Journal of Infectious Diseases|November 2, 2012
Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patternsCarl Aust, Thomas Tolfvenstam, Kristina Broliden, et al.
Transplantation|May 9, 2015
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus DiseaseMarkus Maeurer, Isabelle Magalhaes, Jan Andersson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignanciesKatarina Le Blanc, A John Barrett, Marie Schaffer, et al.
Vaccine|December 3, 2019
Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignanciesSigrun Einarsdottir, Per Ljungman, Bertil Kaijser, et al.
Transfusion Medicine Reviews|December 24, 2005
The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infectionsJohn D Roback, Maureen Conlan, W Lawrence Drew, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2013
Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioningEmma Watz, Mats Remberger, Olle Ringden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCTHamdy Omar, Raija Ahmed, Lalit Rane, et al.
Transplantation and Cellular Therapy|January 31, 2023
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation RecipientsSigrun Einarsdottir, Ingigerdur Sverrisdottir, Krista Vaht, et al.
Blood|April 4, 2002
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplantsPer Ljungman, Rafael de La Camara, Noel Milpied, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Pageof 32

Showing results (81-90 of 320) with videos related to

Sort By:
Pageof 32
Scandinavian Journal of Infectious Diseases|November 2, 2012
Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patternsCarl Aust, Thomas Tolfvenstam, Kristina Broliden, et al.
Transplantation|May 9, 2015
Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus DiseaseMarkus Maeurer, Isabelle Magalhaes, Jan Andersson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignanciesKatarina Le Blanc, A John Barrett, Marie Schaffer, et al.
Vaccine|December 3, 2019
Humoral immunity to tetanus, diphtheria and polio in adults after treatment for hematological malignanciesSigrun Einarsdottir, Per Ljungman, Bertil Kaijser, et al.
Transfusion Medicine Reviews|December 24, 2005
The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infectionsJohn D Roback, Maureen Conlan, W Lawrence Drew, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2013
Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioningEmma Watz, Mats Remberger, Olle Ringden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCTHamdy Omar, Raija Ahmed, Lalit Rane, et al.
Transplantation and Cellular Therapy|January 31, 2023
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation RecipientsSigrun Einarsdottir, Ingigerdur Sverrisdottir, Krista Vaht, et al.
Blood|April 4, 2002
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplantsPer Ljungman, Rafael de La Camara, Noel Milpied, et al.
Frontiers in Immunology|February 27, 2019
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell DepletionEmelie Rådestad, Mikael Sundin, Johan Törlén, et al.
Pageof 32